Contrast Media Market Growth Growth & Trends Trends
The global contrast media market size is expected to reach USD 7.2 billion by 2028, according to a new report published by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2021 to 2028. The increasing burden of chronic diseases is driving the demand for diagnostic imaging procedures which are anticipated to fuel market growth.
The imaging tests such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and X-rays have become an inevitable part of the diagnosis for most diseases. The large-scale penetration of imaging technology in healthcare has increased the demand for chemical agents.
The introduction of artificial intelligence in radiology has improved image reconstruction and enabled the quantification of noninvasive imaging biomarkers. Such developments are anticipated to significantly affect the demand for the chemical agents. For instance, research conducted by Stanford University demonstrated that the use of artificial intelligence-based image reconstruction can reduce and/or eliminate the need for Gadolinium-based Contrast Agents (GBCAs).
Diagnostic imaging modalities are being increasingly used owing to advancements in the underlying technology, ranging from equipment to administration technology. Innovative products, such as syringeless injectors and innovative packaging, help achieve greater accuracy in delivering the right dose of contrast agents as well as reduce wastage. For instance, in August 2020, the U.S. FDA approved the Gadavist Imaging Bulk Package with transfer spike, thus enabling weight-based and multi-patient dosing as well as addressing the issues faced by hospitals related to vial waste. The approval of such innovative packaging is anticipated to increase the demand for the chemical agent.
Contrast Media Market Report Highlights
- Iodinated contrast media was the largest segment in 2020 and is anticipated to remain dominant over the forecast period as the products have excellent radio-opacity and low toxicity
- X-ray/ CT was the largest modality segment in 2020, in terms of revenue share, owing to wide acceptance and cost-efficiency of the techniques
- Cardiovascular diseases are projected to witness the fastest growth over the forecast period due to label extensions for ultrasound and X-ray/CT contrast agents in the U.S.
- North America dominated the market and accounted for the largest revenue share of more than 40.0% in 2020 owing to the presence of well-established healthcare infrastructure and availability of advanced technology
Please note: The report will be updated with the latest data and delivered to you within 2-3 business days.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product type
- 1.1.2. Modality
- 1.1.3. Application
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1: Understanding the market dynamics
- 1.9.2. Objective 2: Understanding the market estimates and forecasts
- 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
- 1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Contrast Media Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Product Pipeline Analysis, by Stage
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.1.1. Increasing prevalence of long-term diseases and complex comorbidities
- 3.4.1.2. Technological advancements
- 3.4.1.3. Label expansions
- 3.4.2. Market Restraint Analysis
- 3.4.2.1. Rising concern about MRI gadolinium agents retained in brain
- 3.4.3. Industry Challenges
- 3.5. Contrast Media: Market Analysis Tools
- 3.5.1. Industry Analysis - Porter’s
- 3.5.1.1. Supplier Power
- 3.5.1.2. Buyer Power
- 3.5.1.3. Substitution Threat
- 3.5.1.4. Threat from new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political Landscape
- 3.5.2.2. Environmental Landscape
- 3.5.2.3. Social Landscape
- 3.5.2.4. Technology Landscape
- 3.5.2.5. Legal Landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- Chapter 4. Contrast Media Market: Segment Analysis, By Product Type, 2016 - 2028 (USD Million)
- 4.1. Segment Dashboard
- 4.2. Definitions & Scope
- 4.3. Product Type Market Share Analysis, 2020 & 2028
- 4.4. Global Contrast Media Market, By Product Type, 2016 to 2028
- 4.5. Market Size & Forecasts And Trend Analysis, 2016 to 2028 for the following
- 4.5.1. Iodinated
- 4.5.2. Barium-based
- 4.5.3. Gadolinium-based
- 4.5.4. Microbubble
- Chapter 5. Contrast Media Market: Segment Analysis, By Modality, 2016 - 2028 (USD Million)
- 5.1. Segment Dashboard
- 5.2. Definitions & Scope
- 5.3. Modality Market Share Analysis, 2020 & 2028
- 5.4. Global Contrast Media Market, By Modality, 2016 to 2028
- 5.5. Market Size & Forecasts And Trend Analysis, 2016 to 2028 for the following
- 5.5.1. X-ray/CT
- 5.5.2. MRI
- 5.5.3. Ultrasound
- Chapter 6. Contrast Media Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)
- 6.1. Segment Dashboard
- 6.2. Definitions & Scope
- 6.3. Application Market Share Analysis, 2020 & 2028
- 6.4. Global Contrast Media Market, By Application, 2019 to 2028
- 6.5. Market Size & Forecasts And Trend Analysis, 2016 to 2028 for the following
- 6.5.1. Cardiovascular disorders
- 6.5.2. Neurological disorders
- 6.5.3. Gastrointestinal disorders
- 6.5.4. Cancer
- 6.5.5. Nephrological disorders
- 6.5.6. Musculoskeletal disorders
- 6.5.7. Others
- Chapter 7. Contrast Media Market: Regional Market Analysis, By Product Type, 2016 - 2028 (USD Million)
- 7.1. Regional Market Dashboard
- 7.2. Definitions & Scope
- 7.3. Regional Market Share Analysis, 2019 & 2028
- 7.4. Market Size, & Forecasts, And Trend Analysis, 2016 to 2028:
- 7.5. North America
- 7.5.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
- 7.5.2. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.5.3. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.5.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.5.5. U.S.
- 7.5.5.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.5.5.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.5.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.5.6. Canada
- 7.5.6.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.5.6.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.5.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6. Europe
- 7.6.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
- 7.6.2. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.3. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.5. U.K.
- 7.6.5.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.5.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.6. Germany
- 7.6.6.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.6.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.7. France
- 7.6.7.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.7.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.8. Italy
- 7.6.8.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.8.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.9. Spain
- 7.6.9.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.9.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.9.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.10. Russia
- 7.6.10.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.10.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.10.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.11. Ukraine
- 7.6.11.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.11.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.11.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.12. Netherlands
- 7.6.12.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.12.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.12.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.13. Switzerland
- 7.6.13.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.13.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.13.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.6.14. Sweden
- 7.6.14.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.6.14.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.6.14.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
- 7.7.2. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.3. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.5. China
- 7.7.5.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.5.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.6. Japan
- 7.7.6.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.6.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.7. India
- 7.7.7.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.7.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.8. Australia
- 7.7.8.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.8.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.9. South Korea
- 7.7.9.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.9.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.9.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.10. Indonesia
- 7.7.10.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.10.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.10.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.11. Malaysia
- 7.7.11.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.11.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.11.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.12. Singapore
- 7.7.12.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.12.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.12.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.13. Thailand
- 7.7.13.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.13.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.13.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.7.14. Taiwan
- 7.7.14.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.7.14.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.7.14.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.8. Latin America
- 7.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
- 7.8.2. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.8.3. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.8.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.8.5. Brazil
- 7.8.5.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.8.5.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.8.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.8.6. Mexico
- 7.8.6.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.8.6.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.8.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.8.7. Argentina
- 7.8.7.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.8.7.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.8.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.8.8. Colombia
- 7.8.8.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.8.8.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.8.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.8.9. Chile
- 7.8.9.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.8.9.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.8.9.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.9. Middle East and Africa
- 7.9.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
- 7.9.2. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.9.3. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.9.4. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.9.5. South Africa
- 7.9.5.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.9.5.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.9.5.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.9.6. Saudi Arabia
- 7.9.6.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.9.6.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.9.6.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.9.7. UAE
- 7.9.7.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.9.7.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.9.7.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.9.8. Egypt
- 7.9.8.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.9.8.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.9.8.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- 7.9.9. Israel
- 7.9.9.1. Market estimates and forecast, by product type, 2016 - 2028 (USD Million)
- 7.9.9.2. Market estimates and forecast, by modality, 2016 - 2028 (USD Million)
- 7.9.9.3. Market estimates and forecast, by application, 2016 - 2028 (USD Million)
- Chapter 8. Contrast Media Market - Competitive Analysis
- 8.1. Key companies profiled
- 8.1.1. Bayer AG
- 8.1.1.1. Company overview
- 8.1.1.2. Financial performance
- 8.1.1.3. Product benchmarking
- 8.1.1.4. Strategic initiatives
- 8.1.2. General Electric Company
- 8.1.2.1. Company overview
- 8.1.2.2. Financial performance
- 8.1.2.3. Product benchmarking
- 8.1.2.4. Strategic initiatives
- 8.1.3. Guerbet
- 8.1.3.1. Company overview
- 8.1.3.2. Financial performance
- 8.1.3.3. Product benchmarking
- 8.1.3.4. Strategic initiatives
- 8.1.4. Lantheus Medical Imaging, Inc.
- 8.1.4.1. Company overview
- 8.1.4.2. Financial performance
- 8.1.4.3. Product benchmarking
- 8.1.4.4. Strategic initiatives
- 8.1.5. Bracco Diagnostic, Inc.
- 8.1.5.1. Company overview
- 8.1.5.2. Financial performance
- 8.1.5.3. Product benchmarking
- 8.1.5.4. Strategic initiatives
- 8.1.6. nano Therapeutics Pvt. Ltd.
- 8.1.6.1. Company overview
- 8.1.6.2. Financial performance
- 8.1.6.3. Product benchmarking
- 8.1.6.4. Strategic initiatives
- 8.1.7. iMAX
- 8.1.7.1. Company overview
- 8.1.7.2. Financial performance
- 8.1.7.3. Product benchmarking
- 8.1.7.4. Strategic initiatives
- 8.1.8. Trivitron Healthcare
- 8.1.8.1. Company overview
- 8.1.8.2. Financial performance
- 8.1.8.3. Product benchmarking
- 8.1.8.4. Strategic initiatives